Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients

15 July 2020: Clinical Research

Shoufeng Liu ^12AE* , Peipei Liu ^2BCDEF* , Po Wang ^3BC , Fang Zhang ^4BD , Lijun Wang ^5BD , Yu Wang ^6BD , Hao Lu ^7B , Xiaofeng Ma ^4AG*

DOI: 10.12659/MSM.924593

Med Sci Monit 2020; 26:e924593

Table 2 Complications and adverse events.

Complication or event	Control n=30	Argatroban n=30	P value
Complications
Deaths	0 (0)	0 (0)	1.00
Myocardial infarctions	0 (0)	0 (0)	1.00
Recurrent strokes	1 (3)	0 (0)	0.31
Cerebral hemorrhage	0 (0)	0 (0)	1.00
Hemorrhage of digestive tract	0 (0)	1 (3)	0.31
Fever (>38°C)	1 (3)	1 (3)	1.00
Event
All events
At least one adverse event	1 (3)	1 (3)	1.00
Any adverse event leading to discontinuation	0 (0)	0 (0)	1.00
Any serious adverse event	0 (0)	0 (0)	1.00
Infection after stroke	1 (3)	1 (3)	1.00
Suspected lung infection	1 (3)	0 (0)	0.31
Urinary tract infection	0 (0)	0 (0)	1.00
Upper respiratory tract infection	0 (0)	1 (3)	0.31
Digestive system infection	0 (0)	0 (0)	1.00
Herpes virus infection	0 (0)	0 (0)	1.00
Antibiotic therapy	1 (3)	0 (0)	0.31
Data are n (%).